Tim Nichol1, Jill Callaghan2, Robert Townsend3, Ian Stockley3, Paul V Hatton2, Christine Le Maitre1, Thomas John Smith1, Robert Akid4. 1. Biomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield, UK. 2. School of Clinical Dentistry, University of Sheffield, Sheffield, UK. 3. Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, UK. 4. Department of Materials, University of Manchester, Manchester, UK.
Abstract
AIMS: The aim of this study was to develop a single-layer hybrid organic-inorganic sol-gel coating that is capable of a controlled antibiotic release for cementless hydroxyapatite (HA)-coated titanium orthopaedic prostheses. METHODS: Coatings containing gentamicin at a concentration of 1.25% weight/volume (wt/vol), similar to that found in commercially available antibiotic-loaded bone cement, were prepared and tested in the laboratory for: kinetics of antibiotic release; activity against planktonic and biofilm bacterial cultures; biocompatibility with cultured mammalian cells; and physical bonding to the material (n = 3 in all tests). The sol-gel coatings and controls were then tested in vivo in a small animal healing model (four materials tested; n = 6 per material), and applied to the surface of commercially pure HA-coated titanium rods. RESULTS: The coating released gentamicin at > 10 × minimum inhibitory concentration (MIC) for sensitive staphylococcal strains within one hour thereby potentially giving effective prophylaxis for arthroplasty surgery, and showed > 99% elution of the antibiotic within the coating after 48 hours. There was total eradication of both planktonic bacteria and established bacterial biofilms of a panel of clinically relevant staphylococci. Mesenchymal stem cells adhered to the coated surfaces and differentiated towards osteoblasts, depositing calcium and expressing the bone marker protein, osteopontin. In the in vivo small animal bone healing model, the antibiotic sol-gel coated titanium (Ti)/HA rod led to osseointegration equivalent to that of the conventional HA-coated surface. CONCLUSION: In this study we report a new sol-gel technology that can release gentamicin from a bioceramic-coated cementless arthroplasty material. In vitro, local gentamicin levels are in excess of what can be achieved by antibiotic-loaded bone cement. In vivo, bone healing in an animal model is not impaired. This, thus, represents a biomaterial modification that may have the potential to protect at-risk patients from implant-related deep infection. Cite this article: Bone Joint J 2021;103-B(3):522-529.
AIMS: The aim of this study was to develop a single-layer hybrid organic-inorganic sol-gel coating that is capable of a controlled antibiotic release for cementless hydroxyapatite (HA)-coated titanium orthopaedic prostheses. METHODS: Coatings containing gentamicin at a concentration of 1.25% weight/volume (wt/vol), similar to that found in commercially available antibiotic-loaded bone cement, were prepared and tested in the laboratory for: kinetics of antibiotic release; activity against planktonic and biofilm bacterial cultures; biocompatibility with cultured mammalian cells; and physical bonding to the material (n = 3 in all tests). The sol-gel coatings and controls were then tested in vivo in a small animal healing model (four materials tested; n = 6 per material), and applied to the surface of commercially pure HA-coated titanium rods. RESULTS: The coating released gentamicin at > 10 × minimum inhibitory concentration (MIC) for sensitive staphylococcal strains within one hour thereby potentially giving effective prophylaxis for arthroplasty surgery, and showed > 99% elution of the antibiotic within the coating after 48 hours. There was total eradication of both planktonic bacteria and established bacterial biofilms of a panel of clinically relevant staphylococci. Mesenchymal stem cells adhered to the coated surfaces and differentiated towards osteoblasts, depositing calcium and expressing the bone marker protein, osteopontin. In the in vivo small animal bone healing model, the antibiotic sol-gel coated titanium (Ti)/HA rod led to osseointegration equivalent to that of the conventional HA-coated surface. CONCLUSION: In this study we report a new sol-gel technology that can release gentamicin from a bioceramic-coated cementless arthroplasty material. In vitro, local gentamicin levels are in excess of what can be achieved by antibiotic-loaded bone cement. In vivo, bone healing in an animal model is not impaired. This, thus, represents a biomaterial modification that may have the potential to protect at-risk patients from implant-related deep infection. Cite this article: Bone Joint J 2021;103-B(3):522-529.
Authors: Christoph E Albers; Wilhelm Hofstetter; Klaus A Siebenrock; Regine Landmann; Frank M Klenke Journal: Nanotoxicology Date: 2011-10-21 Impact factor: 5.913
Authors: S Nast; M Fassbender; N Bormann; S Beck; A Montali; M Lucke; G Schmidmaier; B Wildemann Journal: J Biomater Appl Date: 2016-02-10 Impact factor: 2.646
Authors: Dmitry Gil; Ali E Atici; Rachel L Connolly; Shannon Hugard; Sergey Shuvaev; Keith K Wannomae; Ebru Oral; Orhun K Muratoglu Journal: Bone Joint J Date: 2020-06 Impact factor: 5.082
Authors: Daniëlle Neut; Hilbrand van de Belt; Jim R van Horn; Henny C van der Mei; Henk J Busscher Journal: Biomaterials Date: 2003-05 Impact factor: 12.479
Authors: Georg Gosheger; Jendrik Hardes; Helmut Ahrens; Arne Streitburger; Horst Buerger; Michael Erren; Andreas Gunsel; Fritz H Kemper; Winfried Winkelmann; Christof Von Eiff Journal: Biomaterials Date: 2004-11 Impact factor: 12.479
Authors: D Gothard; E L Smith; J M Kanczler; H Rashidi; O Qutachi; J Henstock; M Rotherham; A El Haj; K M Shakesheff; R O C Oreffo Journal: Eur Cell Mater Date: 2014-10-06 Impact factor: 3.942
Authors: Richard Bright; Daniel Fernandes; Jonathan Wood; Dennis Palms; Anouck Burzava; Neethu Ninan; Toby Brown; Dan Barker; Krasimir Vasilev Journal: Mater Today Bio Date: 2021-12-04
Authors: Katarzyna Kasperkiewicz; Roman Major; Anna Sypien; Marcin Kot; Marcin Dyner; Łukasz Major; Adam Byrski; Magdalena Kopernik; Juergen M Lackner Journal: Molecules Date: 2021-05-24 Impact factor: 4.411